BioMark Diagnostics Inc.
BUX
Rank in Stocks
#26652
BioMark Diagnostics Inc. is an oncology specialist, developing advanced... BioMark Diagnostics Inc. is an oncology specialist, developing advanced diagnostic tools for cancer to enable early detection, continuous patient monitoring, and the assessment of initial treatment efficacy. The firm holds a research partnership with the Icahn School of Medicine, collaborating on clinical trials specifically addressing the early identification of lung cancer. Founded in 2014, its corporate headquarters are situated in Richmond, Canada. BioMark Diagnostics Inc. operates as a subsidiary of Biomark Technologies Inc.
Share Price
$0.34495034
Last synced: 2026-10-16
Market Cap
$36.73M
Change (1 day)
-4.08%
Change (1 year)
53.78%
Country
CA
Trade BioMark Diagnostics Inc. (BUX)
Category
Healthcare
Market Capitalization of BioMark Diagnostics Inc.(BUX)
Market Cap: $36.73M
As of October 2026 BioMark Diagnostics Inc. has a market cap of $36.73M. This makes BioMark Diagnostics Inc. the world's 26652nd most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of BioMark Diagnostics Inc. from 2015 to 2026
BUX compared with Top 5 Most Popular stocks
